Neurilemmoma of the pleura

Summary

Neurilemmoma of the pleura (MONDO:0003926) is a disease. A subtype of peripheral nerve schwannoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	neurilemmoma of the pleura
Mondo ID	MONDO:0003926
DOID	DOID:6564
NCIT	C5418
UMLS	C1335435
MedGen	233863
GARD	0023739
Anatomy (UBERON)	UBERON:0000977
Is cancer (heuristic)	no

Also known as: neurilemmoma of pleura · pleura schwannoma · pleural neurilemmoma · pleural schwannoma · schwannoma of pleura · schwannoma of the pleura

Disease family

This is a subtype of peripheral nerve schwannoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorder › peripheral nervous system disorder › peripheral nervous system neoplasm › nerve sheath neoplasm › schwannoma › peripheral nerve schwannoma › neurilemmoma of the pleura

Related subtypes (3): schwannoma of ureter, schwannoma of jugular foramen, mediastinal schwannoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.